Clover Health's CEO Just Sold 62,711 Shares for Tax Withholding. The Bigger News Comes Next Week.
Toy retains a $44.68 million direct stake after the non-discretionary sale triggered by RSU vesting. Remaining tranches vest quarterly through October 2028, signaling predictable future sell-to-cover activity.
Overview
Andrew Toy, Chief Executive Officer of Clover Health Investments, Corp. (NASDAQ:CLOV), sold 62,711 shares of Class A Common Stock on July 15, 2026, according to a recent SEC Form 4 filing.
Transaction value based on SEC Form 4 weighted average sale price ($4.67); post-transaction value based on July 15, 2026 market close ($4.68).
Clover Health Investments operates as a U.S.-based healthcare insurer with a $2.4 billion market capitalization and TTM revenue of $2.2 billion, leveraging proprietary software technology to differentiate its Medicare Advantage offerings. The company's competitive strategy centers on its Clover Assistant platform, which aims to enhance member outcomes and operational efficiency within the Medicare Advantage market. With 724 employees, Clover Health represents a technology-enabled approach to healthcare insurance serving a large and growing demographic of Medicare beneficiaries.
Details
Source
Originally published at www.fool.com.